photo of Lenore Goldfarb
recurrent miscarriage

Antiphospholipid antibodies, infertility and recurrent miscarriage

Curr Opin Obstet Gynecol 1997 Aug;9(4):279-82 (ISSN: 1040-872X)
Rai R; Regan L
Department of Obstetrics and Gynaecology, Imperial College School of Medicine at St Mary’s, London, UK.

Antiphospholipid antibodies are found in 15% of women with recurrent miscarriage. These women have only a 10% live birth rate in subsequent pregnancies in which no pharmacological treatment is given. Pregnancy loss is often attributable to uteroplacental insufficiency subsequent to placental thrombosis. Treatment with low dose aspirin improves the live birth rate amongst women with antiphospholipid antibodies to 40% but this is further and significantly increased to 70% when they are treated with aspirin together with low-dose heparin.

print this page back

If you value this service, kindly consider a donation to the Canadian Breastfeeding Foundation (registered charity). Earmark the donation for the International Breastfeeding Centre (Newman Breastfeeding Clinic) and/or the Goldfarb Breastfeeding Program.

Donate online:

Donate by mail: Canadian Breastfeeding Foundation, 5890 Monkland Ave, Suite 16, Montreal, Quebec, Canada H4A 1G2.

© 2002-2018 Dr. Lenore Goldfarb, PhD, CCC, IBCLC, ALC and contributing authors to All rights reserved.

Disclaimer: All material provided in is provided for educational purposes only. Consult your physician regarding the advisability of any opinions or recommendations with respect to your individual situation.